Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Levetiracetam-induced acute psychotic episode.

Literature DB >> 23198271

Levetiracetam-induced acute psychotic episode.

Srinivas Dannaram, Dileep Borra, Madhuri Pulluri, Prachi Jindal, Ashish Sharma.

Abstract

Entities: Chemical Disease

Year: 2012 PMID： 23198271 PMCID： PMC3508956

Source DB: PubMed Journal: Innov Clin Neurosci ISSN： 2158-8333

× No keyword cloud information.

10 in total

1. Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.

Authors: Rainer Surges; Kirill E Volynski; Matthew C Walker
Journal: Ther Adv Neurol Disord Date: 2008-07 Impact factor: 6.570

2. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.

Authors: Norman Delanty; John Jones; Françoise Tonner
Journal: Epilepsia Date: 2011-11-02 Impact factor: 5.864

Review 3. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression.

Authors: B P Hermann; M Seidenberg; B Bell
Journal: Epilepsia Date: 2000 Impact factor: 5.864

Review 4. Pharmacokinetic profile of levetiracetam: toward ideal characteristics.

Authors: P N Patsalos
Journal: Pharmacol Ther Date: 2000-02 Impact factor: 12.310

5. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.

Authors: S Noachtar; E Andermann; P Meyvisch; F Andermann; W B Gough; J Schiemann-Delgado
Journal: Neurology Date: 2008-02-19 Impact factor: 9.910

Review 6. Emergent complications of the newer anticonvulsants.

Authors: Jeffrey F Wade; Chat V Dang; Lowell Nelson; Jonathan Wasserberger
Journal: J Emerg Med Date: 2008-08-30 Impact factor: 1.484

7. Psychiatric adverse events during levetiracetam therapy.

Authors: M Mula; M R Trimble; A Yuen; R S N Liu; J W A S Sander
Journal: Neurology Date: 2003-09-09 Impact factor: 9.910

8. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents.

Authors: J-M Rigo; G Hans; L Nguyen; V Rocher; S Belachew; B Malgrange; P Leprince; G Moonen; I Selak; A Matagne; H Klitgaard
Journal: Br J Pharmacol Date: 2002-07 Impact factor: 8.739

9. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy.

Authors: S F Berkovic; R C Knowlton; R F Leroy; J Schiemann; U Falter
Journal: Neurology Date: 2007-07-11 Impact factor: 9.910

10. Epilepsy and psychiatric comorbidity: a nationally representative population-based study.

Authors: Dheeraj Rai; Michael P Kerr; Sally McManus; Vesna Jordanova; Glyn Lewis; Traolach S Brugha
Journal: Epilepsia Date: 2012-05-11 Impact factor: 5.864

10 in total

5 in total

Levetiracetam-induced acute psychotic episode.

1. Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.

2. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.

Review 3. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression.

Review 4. Pharmacokinetic profile of levetiracetam: toward ideal characteristics.

5. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.

Review 6. Emergent complications of the newer anticonvulsants.

7. Psychiatric adverse events during levetiracetam therapy.

8. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents.

9. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy.

10. Epilepsy and psychiatric comorbidity: a nationally representative population-based study.

1. Levetiracetam Induced Neuropsychiatric Manifestation in a 5-year-old Boy.

2. Levetiracetam-induced acute psychosis in a child.

3. Levetiracetam induced acute reversible psychosis in a patient with uncontrolled seizures.

4. Levetiracetam-Induced Psychosis in the Setting of Intracranial Cavernomas.

5. Levetiracetam-induced aggression and acute behavioral changes: A case report and literature review.